SIU 2018: Prostate Cancer Screening: Japanese Perspective
Seoul, South-Korea (UroToday): Dr. Egawa began his presentation by demonstrating some global data on prostate cancer. In 2008 the global prevalence of prostate cancer was ~899000 cases with 258,000 new cases per year, which are predicted to increase to 1.7 million by 2030. When assessing global data on prostate cancer, several factors must be considered, These include genetic variation, lifestyle differences, screening rates and accessibility to globally acceptable cancer registries.
SIU 2018: Prostate Cancer Screening: American Perspective
Seoul, South-Korea (UroToday.com) Matthew Cooperberg, MD gave a presentation on prostate cancer screening from an American perspective. Prostate cancer is the most prevalent cancer in the US and the second highest cancer causing mortality in men (Figure 1). The goal of screening is to find aggressive prostate cancer early and cure it before it spreads beyond the prostate. Most cancer cases found by screening do not need to be treated and can be safely managed with active surveillance.